|
Oxidant stress
Citations 221-230 of 433 total displayed.
|
Past content
(since Jan 1999):
|
- Basic Science Reports
Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator–Activated Receptor- Agonist in Hypercholesterolemia
- Ling Tao, Hui-Rong Liu, Erhe Gao, Zhi-Ping Teng, Bernard L. Lopez, Theodore A. Christopher, Xin-Liang Ma, Ines Batinic-Haberle, Robert N. Willette, Eliot H. Ohlstein, and Tian-Li Yue
Circulation 2003;108:2805-2811; published online before print as doi:10.1161/01.CIR.0000097003.49585.5E
[Abstract]
[Full text]
- Articles
Coronary Microvascular Endothelial Stunning After Acute Pressure Overload in the Conscious Dog Is Caused by Oxidant Processes. The Role of Angiotensin II Type 1 Receptor and NAD(P)H Oxidase
- Shintaro Kinugawa, Heiner Post, Pawel M. Kaminski, Xiaoping Zhang, Xiaobin Xu, Harer Huang, Fabio A. Recchia, Manuel Ochoa, Michael S. Wolin, Gabor Kaley, and Thomas H. Hintze
Circulation published December 1, 2003, doi:10.1161/01.CIR.0000096488.78151.97
[Abstract]
- Brief Rapid Communications
Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Endothelial Function in Salt-Induced Hypertension
- Matthias Hermann, Giovanni Camici, Aisha Fratton, David Hurlimann, Felix C. Tanner, Jens P. Hellermann, Martin Fiedler, Joachim Thiery, Michel Neidhart, Renate E. Gay, Steffen Gay, Thomas F. Lüscher, and Frank Ruschitzka
Circulation 2003;108:2308-2311; published online before print as doi:10.1161/01.CIR.0000101683.30157.0B
[Abstract]
[Full text]
- Articles
Antioxidative, Antinitrative, and Vasculoprotective Effects of a Peroxisome Proliferator-Activated Receptor- Agonist in Hypercholesterolemia
- Ling Tao, Hui-Rong Liu, Erhe Gao, Zhi-Ping Teng, Bernard L. Lopez, Theodore A. Christopher, Xin-Liang Ma, Ines Batinic-Haberle, Robert N. Willette, Eliot H. Ohlstein, and Tian-Li Yue
Circulation published November 10, 2003, doi:10.1161/01.CIR.0000097003.49585.5E
[Abstract]
- Basic Science Reports
Cariporide (HOE642), a Selective Na+-H+ Exchange Inhibitor, Inhibits the Mitochondrial Death Pathway
- Yasushi Teshima, Masaharu Akao, Steven P. Jones, and Eduardo Marbán
Circulation 2003;108:2275-2281; published online before print as doi:10.1161/01.CIR.0000093277.20968.C7
[Abstract]
[Full text]
- Brief Rapid Communications
Differential Effects of Selective Cyclooxygenase-2 Inhibitors on Endothelial Function in Salt-Induced Hypertension
- Matthias Hermann, Giovanni Camici, Aisha Fratton, David Hurlimann, Felix C. Tanner, Jens P. Hellermann, Martin Fiedler, Joachim Thiery, Michel Neidhart, Renate E. Gay, Steffen Gay, Thomas F. Lüscher, and Frank Ruschitzka
Circulation published November 3, 2003, doi:10.1161/01.CIR.0000101683.30157.0B
[Abstract]
- Review: Clinical Cardiology: New Frontiers
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
- Kathy K. Griendling and Garret A. FitzGerald
Circulation 2003;108:2034-2040, doi:10.1161/01.CIR.0000093661.90582.c4
[Full text]
- Mini-Review: Expert Opinions
Testing Endothelial Vasomotor Function: Nitric Oxide, a Multipotent Molecule
- Peter Ganz and Joseph A. Vita
Circulation 2003;108:2049-2053, doi:10.1161/01.CIR.0000089507.19675.F9
[Full text]
- Mini-Review: Expert Opinions
Endothelial Function Testing as a Biomarker of Vascular Disease
- Subodh Verma, Michael R. Buchanan, and Todd J. Anderson
Circulation 2003;108:2054-2059, doi:10.1161/01.CIR.0000089191.72957.ED
[Full text]
- Mini-Review: Expert Opinions
Endothelial Dysfunction
- James T. Willerson and Dean J. Kereiakes
Circulation 2003;108:2060-2061, doi:10.1161/01.CIR.0000099580.72044.83
[Full text]
|
|
